Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Singh, Kathryn
DOB:	24-DEC-1977 (Age: 48)
Gender:	female
Address:	166 Brian pine PA37 Robertsonmouth (United Kingdom)
ID:	1354-713350-7 (ECI)

Report
Date:	10-DEC-2017

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Lorn Medical Centre PA34 4 Oban (United Kingdom)

Specimen
Collected:	10-DEC-2017

Chemistry

Test	10-DEC-2017	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	6.3 H	4.0 - 5.6	%
Glucose [Mass/volume] in Blood	71.4	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	9.6	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	1.4 H	0.5 - 1.1	mg/dL
Calcium [Mass/volume] in Blood	9.8	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	139.9	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.6	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	104.2	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	21.7 L	22 - 32	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	280.7 H	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	140.9	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	187.3 H	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	65.2 H	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated HbA1c, indicating poor long-term glycemic control, and mildly increased creatinine, suggesting possible renal impairment. Lipid profile reveals hypercholesterolemia and high LDL, increasing cardiovascular risk. Total CO2 is slightly low, which may indicate mild metabolic acidosis. Further clinical correlation and follow-up are recommended for diabetes, renal function, and cardiovascular risk management.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows elevated HbA1c, indicating poor long-term glycemic control, and mildly increased creatinine, suggesting possible renal impairment. Lipid profile reveals hypercholesterolemia and high LDL, increasing cardiovascular risk. Total CO2 is slightly low, which may indicate mild metabolic acidosis. Further clinical correlation and follow-up are recommended for diabetes, renal function, and cardiovascular risk management.